PIVOTAL BIOVENTURE PARTNERS
Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. They invest in privately held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. They invest at all stages in a company’s evolution, from company creation through mid and late stage clinical development. Their team brings diverse experience in venture capital, company building, and drug discovery and development to the table in working with entrepreneurs to advance their businesses.
PIVOTAL BIOVENTURE PARTNERS
Social Links:
Industry:
Biotechnology Venture Capital
Founded:
2017-01-04
Status:
Active
Contact:
415-697-1002
Email Addresses:
[email protected]
Technology used in webpage:
SPF DMARC Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Facebook Sharer GoDaddy DNS COVID-19 WP Engine Apple ICloud Mail
Similar Organizations
Apollo Health Ventures
Apollo Health Ventures is a venture capital firm investing in seed and early stage biotechnology companies.
Formic Ventures
Formic Ventures is a diversified venture capital firm that makes early-stage investments in biotechnology startups
Bionova Capital
Bionova Capital is a healthcare-focused venture capital firm, investing in early-stage startups across Europe.
Iris Family Office
The Iris Family Office is San Francisco based and invests in multiple asset classes, but primarily in late stage tech companies.
K2VC
K2VC is a venture capital firm investing in early stage technology startups.
Scale-Up Venture Capital
Scale-Up VC is a venture capital firm that makes investments in late and growth stage technology companies.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-10-31 | Evommune | Pivotal bioVenture Partners investment in Series C - Evommune | 115 M USD |
| 2024-05-07 | Zenas BioPharma | Pivotal bioVenture Partners investment in Series C - Zenas BioPharma | 200 M USD |
| 2024-02-13 | BioAge Labs | Pivotal bioVenture Partners investment in Series D - BioAge Labs | 170 M USD |
| 2023-09-27 | Avalyn Pharma | Pivotal bioVenture Partners investment in Series C - Avalyn Pharma | 175 M USD |
| 2023-04-26 | Evommune | Pivotal bioVenture Partners investment in Series B - Evommune | 50 M USD |
| 2023-03-08 | Heranova Lifesciences | Pivotal bioVenture Partners investment in Seed Round - Heranova Lifesciences | 10 M USD |
| 2023-03-03 | Oculis | Pivotal bioVenture Partners investment in Post-IPO Equity - Oculis | 91 M USD |
| 2022-11-07 | Zenas BioPharma | Pivotal bioVenture Partners investment in Series B - Zenas BioPharma | 118 M USD |
| 2022-02-23 | Plexium | Pivotal bioVenture Partners investment in Series B - Plexium | 102 M USD |
| 2022-02-10 | Arkuda Therapeutics | Pivotal bioVenture Partners investment in Series B - Arkuda Therapeutics | 64 M USD |
More informations about "Pivotal bioVenture Partners"
Pivotal bioVenture Partners | Healthcare Venture Capital
Pivotal bioVenture Partners is the venture capital arm of Pivotal Life Sciences. The Pivotal bioVenture Partners team brings together backgrounds that include diverse entrepreneurial and scientific experience in clinical medicine, …See details»
Pivotal bioVenture Partners - Crunchbase
Pivotal bioVenture Partners may be growing as it has recently closed a significant fund, which is indicative of increased financial resources available for investment. The firm unveiled a $389 million fund, which brings its total commitments to …See details»
Pivotal bioVenture Partners - LinkedIn
Pivotal bioVenture Partners (U.S.), an affiliate of Pivotal Life Sciences We back the brightest minds in life sciences. Our seasoned investment team brings over 50 years combined biotech venture ...See details»
Pivotal Life Sciences investment portfolio - PitchBook
Aug 11, 2023 Founded in 2017, Pivotal bioVenture Partners is a venture capital investment firm based in San Francisco, California. The firm prefers to invest in the life sciences and …See details»
Vincent Cheung - Pivotal Life Sciences
Vincent is the Chairman of Pivotal Life Sciences. He founded Pivotal bioVenture Partners in 2017 and Pivotal bioVenture Partners China in 2018. Vincent is also the Managing Director and the …See details»
Pivotal bioVenture Partners - Investments, Portfolio & Company Exits
Pivotal bioVenture Partners has made 5 diversity investments. Their most recent diversity investment was on Feb 13, 2024, when BioAge Labs raised. obfuscated. obfuscated. …See details»
Pivotal Bioventure Partners - Overview, News & Similar ... - ZoomInfo
Nov 7, 2022 Who is Pivotal Bioventure Partners. Pivotal bioVenture Partners is a $300 million life sciences venture capital fund established in 2017. We invest in privately held North …See details»
Pivotal Life Sciences | Institution Profile - Private Equity International
Pivotal Life Sciences overview Founded in 2017, Pivotal Life Sciences is a venture capital firm based in San Francisco, Hong Kong and Shanghai under the name of Pivotal bioVenture …See details»
Pivotal bioVenture Partners - Venture Capital Firm | Signal - NFX
Pivotal bioVenture Partners is a San Francisco-based venture capital firm investing in early stage biotechnology companies. Show more. Founded: 2017. Firm Location: San Francisco, …See details»
Pivotal BioVenture Partners | Institution Profile | Private Equity ...
Founded in 2017, Pivotal BioVenture Partners is a California-based investment firm that focuses on early-stage investments in biotech companies across Europe, North America and Asia …See details»
Pivotal bioVenture Partners unveils $389M fund
Dec 18, 2023 Pivotal bioVenture Partners has closed its second fund of $389 million, money that will go toward North American and European companies working to develop new therapeutics. | Pivotal bioVenture ...See details»
In Second Fund, Pivotal Raises $389M to Create and Support ...
Dec 18, 2023 Pictured: San Francisco’s Golden Gate Bridge/ iStock, bloodua San Francisco–based venture capital firm Pivotal bioVenture Partners announced Monday it has …See details»
Pivotal bioVenture Partners closes $300M early biotech fund
Mar 16, 2017 The Nan Fung Group’s venture capital firm Pivotal bioVenture Partners has raised its first fund, totaling $300 million, as it looks to help early-stage life science startups get off the …See details»
Pivotal bioVenture raises the stakes in biotech and pharmaceutical ...
Dec 18, 2023 Pivotal bioVenture raises the stakes in biotech and pharmaceutical support. The latest $389m pledge follows an initial investment of $300m in 2017 that was raised to fund …See details»
Pivotal Therapeutics Inc. 7820801 - Canada Business Directory
Pivotal Therapeutics Inc. is a company governing under the Canada Business Corporations Act - 7 April 2011 (Thursday). It was incorporated on 7 April 2011 (Thursday) in Canada and as of 7 …See details»
Pivotal bioVenture Partners - Updates, News, Events ... - Crunchbase
Pivotal bioVenture Partners may be growing as it has recently closed a significant fund, which is indicative of increased financial resources available for investment. The firm unveiled a $389 …See details»
Pivotal bioVenture Partners - Contacts, Employees, Board …
Pivotal bioVenture Partners has 8 current employee profiles, including Managing Partner Heather Preston. Contacts. Edit Contacts Section. Job Department. Protected Content. Sr. Associate. …See details»
BioCentury - Pivotal Therapeutics board of directors update
May 19, 2014 Pivotal Therapeutics board of directors update. WIR Staff. May 19, 2014 7:00 AM UTC. Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: …See details»
Pivotal Therapeutics Inc. - Company & Director Informations
Pivotal Therapeutics Inc. is a Distributing corporation company type , located at 81 Zenway Blvd., Unit 10 Woodbridge ON L4H 0S5 Canada. It was incoporated on 07-Apr-2011, the company's …See details»
Pivotal Therapeutics Company Profile - Office Locations ... - Craft
May 24, 2024 Partners. Resources. Company. Toggle menu. ... Stock Price. $0. 2024-05-24. Market Capitalization. $172.4 K. 2024-05-24. Pivotal Therapeutics Summary. Company …See details»